Endocrinology

>

The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

Intensive Blood Pressure Regimen Lowers CVD Risk in People with T2D | Image Credit: American Heart Association
Intensive Blood Pressure Regimen Lowers CVD Risk in People with T2D

November 16th 2024

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Committee Casts Negative Vote on Sotagliflozin in Type 1 Diabetes

November 2nd 2024

Henning Bliddal, MD, MSci., The Parker Institute, Copenhagen University Hospital, Denmark
Semaglutide Reduces Knee Osteoarthritis Pain in People With Obesity

November 1st 2024

10-Year Follow-Up Shows Lasting Benefits of Bariatric Surgery for Teens with Severe Obesity
10-Year Follow-Up Shows Lasting Benefits of Bariatric Surgery for Teens with Severe Obesity

October 30th 2024

Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center
Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD

October 21st 2024

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Latest CME Events & Activities
<1
...
145146147148149
© 2024 MJH Life Sciences

All rights reserved.